The exploration of hydroxychloroquine's ability to modulate autophagy has led to its investigation in age-related diseases, such as Alzheimer's and Parkinson's. By potentially clearing abnormal protein aggregates,
Hydroquin offers a promising avenue for research into neurodegenerative diseases, where dysregulated autophagy plays a critical role. This could pave the way for new therapeutic strategies aimed at mitigating the progression of these debilitating conditions.
